Main Article Content
Background - Prostatic cancer is second most frequent cancer in world and is the sixth leading cause of mortality in men due to malignancies. Histopathological diagnosis of various prostatic proliferative lesions may pose problems due to presence of mimickers. Hence, p63 is used as an immunochemical marker. P63 is a nuclear protein. It is confined to basal cells/myoepithelial cells of prostate gland.